A long-term multicenter study: Entecavir versus Tenofovir in treatment of nucleos(t)ide analogue-naive chronic hepatitis B patients.


Kayaaslan B., Akinci E., Ari A., Tufan Z. , Alpat S. N. , Gunal O., ...More

Clinics and research in hepatology and gastroenterology, vol.42, no.1, pp.40-47, 2018 (Journal Indexed in SCI Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 42 Issue: 1
  • Publication Date: 2018
  • Doi Number: 10.1016/j.clinre.2017.06.008
  • Title of Journal : Clinics and research in hepatology and gastroenterology
  • Page Numbers: pp.40-47

Abstract

Background: Entecavir (ETV) and tenofovir disoproxil fumarat (TDF) are the two first-line therapies recommended in the treatment of chronic hepatitis B because of having potent antiviral effect and high genetic barriers against resistance. We aimed to compare efficacy of these drugs and to evaluate predictors of viral suppression.